These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8104608)

  • 1. Neuroleptics in learning disability. Alternatives to drugs are unproved.
    Branford D; Collacott RA
    BMJ; 1993 Sep; 307(6904):621. PubMed ID: 8104608
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptics in learning disability. Other psychotropic drugs used sparingly.
    Kohen D
    BMJ; 1993 Sep; 307(6904):621. PubMed ID: 8104610
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptics in learning disability. Their use is sometimes justified.
    Yeo J
    BMJ; 1993 Sep; 307(6904):620-1. PubMed ID: 8104607
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptics in learning disability. Inappropriate use in elderly people.
    Curless R; Ford G
    BMJ; 1993 Sep; 307(6904):621. PubMed ID: 8104609
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptics, learning disability, and the community: some history and mystery.
    Manchester D
    BMJ; 1993 Jul; 307(6897):184-7. PubMed ID: 8102074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pressure to prescribe antipsychotic drugs in learning disability too.
    Yates S
    BMJ; 2012 Apr; 344():e2455. PubMed ID: 22474277
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of the long term efficacy of antipsychotic drugs in controlling the behavior of institutionalized retardates.
    Zimmermann RL; Heistad GT
    J Am Acad Child Psychiatry; 1982 Mar; 21(2):136-43. PubMed ID: 6121828
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
    MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271
    [No Abstract]   [Full Text] [Related]  

  • 9. Challenges and pitfalls of antipsychotic prescribing in people with learning disability.
    Alexander RT; Shankar R; Cooper SA; Bhaumik S; Hastings R; Kapugama CL; Tromans SJ; Roy A
    Br J Gen Pract; 2017 Aug; 67(661):372-373. PubMed ID: 28751349
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs, learning and cognitive function in children--an update.
    Werry JS
    J Child Psychol Psychiatry; 1988 Mar; 29(2):129-41. PubMed ID: 2897374
    [No Abstract]   [Full Text] [Related]  

  • 11. Maladaptive behaviors associated with neuroleptic drug maintenance.
    Chadsey-Rusch J; Sprague RL
    Am J Ment Retard; 1989 May; 93(6):607-17. PubMed ID: 2566315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic medication for those with both schizophrenia and learning disability.
    Duggan L; Brylewski J
    Cochrane Database Syst Rev; 2000; (2):CD000030. PubMed ID: 10796285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic medication versus placebo for people with both schizophrenia and learning disability.
    Duggan L; Brylewski J
    Cochrane Database Syst Rev; 2004 Oct; 2004(4):CD000030. PubMed ID: 15494985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine in PDD.
    Horrigan JP; Barnhill LJ; Courvoisie HE
    J Am Acad Child Adolesc Psychiatry; 1997 Sep; 36(9):1166-7. PubMed ID: 9291716
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing antipsychotic medication in people with a learning disability.
    Ahmed Z; Fraser W; Kerr MP; Kiernan C; Emerson E; Robertson J; Felce D; Allen D; Baxter H; Thomas J
    Br J Psychiatry; 2000 Jan; 176():42-6. PubMed ID: 10789325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Active treatment of behavior problems of the mentally retarded. Sultopride].
    Amedro MJ; Couquiaud FG
    Sem Hop; 1983 Dec; 59(47):3327-31. PubMed ID: 6141640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with the successful or unsuccessful withdrawal of antipsychotic drug therapy prescribed for people with learning disabilities.
    Branford D
    J Intellect Disabil Res; 1996 Aug; 40 ( Pt 4)():322-9. PubMed ID: 8884587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in psychotic symptoms and social functioning after augmentation of paliperidone with clozapine in a patient with schizoaffective disorder.
    Hou YC
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E26. PubMed ID: 24515699
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of neuroleptics on the social behavior disorders of schizophrenic patients].
    Mahé V
    Encephale; 2003 Sep; 29(Pt 2):S28-30. PubMed ID: 14710533
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinuation of thioridazine. What happened to thioridazine?
    Arshad P; Morcos M; Sridharan B
    BMJ; 2002 Oct; 325(7370):967. PubMed ID: 12402926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.